Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia

Andy C. Rawstron(University of Leeds), Peter Hillmen(Leeds Teaching Hospitals NHS Trust), Marwan Kwok(Queen Elizabeth Hospital Birmingham), Roger G. Owen(Leeds Teaching Hospitals NHS Trust), Andrew Jack(University of Alberta), Marieth Plummer(Leeds Teaching Hospitals NHS Trust), Sheila J.M. O’Connor(Leeds Teaching Hospitals NHS Trust), James A. L. Fenton(Leeds Teaching Hospitals NHS Trust), Ruth de Tute(Leeds Teaching Hospitals NHS Trust), Stephen J. Richards(St James's University Hospital), Fiona Bennett(Leeds Teaching Hospitals NHS Trust)
New England Journal of Medicine
August 6, 2008
10.1056/nejmoa075290
Cited by 605

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k